CD4 and cryptococcosis: Although much work remains toward the development of a cross-protective cryptococcal vaccine, these studies provide a foundation for understanding the protective host immune response to multiple clinically relevant strains of Cryptococcus and the need to identify protective CD4+ T cell epitopes that can be incorporated into a vaccine formulation that provides broad-spectrum protection against cryptococcosis.